Pathogens Implicated in Periodontal Diseases

Periodontal diseases are associated with a variety of pathogenic microorganisms. Below is a list of key pathogens implicated in different forms of periodontal disease, along with their associations:

General Pathogens Associated with Periodontal Diseases

• Actinobacillus actinomycetemcomitans:

  • Strongly associated with destructive periodontal disease.

• Porphyromonas gingivalis:

  • A member of the "black pigmented Bacteroides group" and a significant contributor to periodontal disease.

• Bacteroides forsythus:

  • Associated with chronic periodontitis.

• Spirochetes (Treponema denticola):

  • Implicated in various periodontal conditions.

• Prevotella intermedia/nigrescens:

  • Also belongs to the "black pigmented Bacteroides group" and is associated with several forms of periodontal disease.

• Fusobacterium nucleatum:

  • Plays a role in the progression of periodontal disease.

• Campylobacter rectus:

  • These organisms include members of the new genus Wolinella and are associated with periodontal disease.

Principal Bacteria Associated with Specific Periodontal Diseases

1. Adult Periodontitis:

   • Porphyromonas gingivalis
   • Prevotella intermedia
   • Bacteroides forsythus
   • Campylobacter rectus

2. Refractory Periodontitis:

   • Bacteroides forsythus
   • Porphyromonas gingivalis
   • Campylobacter rectus
   • Prevotella intermedia

3. Localized Juvenile Periodontitis (LJP):

   • Actinobacillus actinomycetemcomitans
   • Capnocytophaga

4. Periodontitis in Juvenile Diabetes:

   • Capnocytophaga
   • Actinobacillus actinomycetemcomitans

5. Pregnancy Gingivitis:

   • Prevotella intermedia

6. Acute Necrotizing Ulcerative Gingivitis (ANUG):

   • Prevotella intermedia
   • Intermediate-sized spirochetes

Periodontal Medicaments

Periodontal diseases often require adjunctive therapies to traditional mechanical treatments such as scaling and root planing. Various medicaments have been developed to enhance the healing process and control infection in periodontal tissues. This lecture will discuss several periodontal medicaments, their compositions, and their clinical applications.

1. Elyzol

• Composition:
  • Elyzol is an oil-based gel containing 25% metronidazole. It is formulated with glyceryl mono-oleate and sesame oil.
• Clinical Use:
  • Elyzol has been found to be equivalent to scaling and root planing in terms of effectiveness for treating periodontal disease.
  • However, no adjunctive effects beyond those achieved with mechanical debridement have been demonstrated.

2. Actisite

• Composition:

  • Actisite consists of tetracycline-containing fibers.
  • Each fiber has a diameter of 0.5 mm and contains 12.7 mg of tetracycline per 9 inches of fiber.

• Clinical Use:

  • The fibers are placed directly into periodontal pockets, where they release tetracycline over time, helping to reduce bacterial load and promote healing.

3. Arestin

• Composition:

  • Arestin contains minocycline, which is delivered as a biodegradable powder in a syringe.

• Clinical Use:

  • Arestin is indicated for the treatment of periodontal disease and is applied directly into periodontal pockets, where it provides localized antibiotic therapy.

4. Atridox

• Composition:

  • Atridox contains 10% doxycycline in a syringeable gel system that is biodegradable.

• Clinical Use:

  • The gel is injected into periodontal pockets, where it solidifies and releases doxycycline over time, aiding in the management of periodontal disease.

5. Dentamycin and Periocline

• Composition:

  • Both Dentamycin and Periocline contain 2% minocycline hydrochloride.

• Clinical Use:

  • These products are used similarly to other local delivery systems, providing localized antibiotic therapy to reduce bacterial infection in periodontal pockets.

6. Periochip

• Composition:

  • Periochip is a biodegradable chip that contains chlorhexidine.

• Clinical Use:

  • The chip is placed in the gingival crevice, where it releases chlorhexidine over time, providing antimicrobial action and helping to control periodontal disease.

Changes in Plaque pH After Sucrose Rinse

The pH of dental plaque is a critical factor in the development of dental caries and periodontal disease. Key findings from various studies that investigated the changes in plaque pH following carbohydrate rinses, particularly focusing on sucrose and glucose.

Key Findings from Studies

1. Monitoring Plaque pH Changes:

   • A study reported that changes in plaque pH after a sucrose rinse were monitored using plaque sampling, antimony and glass electrodes, and telemetry.
   • Results:
     • The minimum pH at approximal sites (areas between teeth) was approximately 0.7 pH units lower than that on buccal surfaces (outer surfaces of the teeth).
     • The pH at the approximal site remained below resting levels for over 120 minutes.
     • The area under the pH response curves from approximal sites was five times greater than that from buccal surfaces, indicating a more significant and prolonged acidogenic response in interproximal areas.

2. Stephan's Early Studies (1935):

   • Method: Colorimetric measurement of plaque pH suspended in water.
   • Findings:
     • The pH of 211 plaque samples ranged from 4.6 to 7.0.
     • The mean pH value was found to be 5.9, indicating a generally acidic environment in dental plaque.

3. Stephan's Follow-Up Studies (1940):

   • Method: Use of an antimony electrode to measure in situ plaque pH after rinsing with sugar solutions.
   • Findings:
     • A 10% solution of glucose or sucrose caused a rapid drop in plaque pH by about 2 units within 2 to 5 minutes, reaching values between 4.5 and 5.0.
     • A 1% lactose solution lowered the pH by 0.3 units, while a 1% glucose solution caused a drop of 1.5 units.
     • A 1% boiled starch solution resulted in a reduction of 1.5 pH units over 51 minutes.
     • In all cases, the pH tended to return to initial values within approximately 2 hours.

4. Investigation of Proximal Cavities:

   • Studies of actual proximal cavities opened mechanically showed that the lowest pH values ranged from 4.6 to 4.1.
   • After rinsing with a 10% glucose or sucrose solution, the pH in the plaque dropped to between 4.5 and 5.0 within 2 to 5 minutes and gradually returned to baseline levels within 1 to 2 hours.

Implications

• The studies highlight the significant impact of carbohydrate exposure, particularly sucrose and glucose, on the pH of dental plaque.
• The rapid drop in pH following carbohydrate rinses indicates an acidogenic response from plaque microorganisms, which can contribute to enamel demineralization and caries development.
• The prolonged acidic environment in approximal sites suggests that these areas may be more susceptible to caries due to the slower recovery of pH levels.

Periodontal Bone Grafts

Bone grafting is a critical procedure in periodontal surgery, aimed at restoring lost bone and supporting the regeneration of periodontal tissues.

1. Bone Blend

 Bone blend is a mixture of cortical or cancellous bone that is procured using a trephine or rongeurs, placed in an amalgam capsule, and triturated to achieve a slushy osseous mass. This technique allows for the creation of smaller particle sizes, which enhances resorption and replacement with host bone.

Particle Size: The ideal particle size for bone blend is approximately 210 x 105 micrometers.

Rationale: Smaller particle sizes improve the chances of resorption and integration with the host bone, making the graft more effective.

2. Types of Periodontal Bone Grafts

A. Autogenous Grafts

Autogenous grafts are harvested from the patient’s own body, providing the best compatibility and healing potential.

1. Cortical Bone Chips

   • History: First used by Nabers and O'Leary in 1965.
   • Characteristics: Composed of shavings of cortical bone removed during osteoplasty and ostectomy from intraoral sites.
   • Challenges: Larger particle sizes can complicate placement and handling, and there is a potential for sequestration. This method has largely been replaced by autogenous osseous coagulum and bone blend.

2. Osseous Coagulum and Bone Blend

   • Technique: Intraoral bone is obtained using high- or low-speed round burs and mixed with blood to form an osseous coagulum (Robinson, 1969).
   • Advantages: Overcomes disadvantages of cortical bone chips, such as inability to aspirate during collection and variability in quality and quantity of collected bone.
   • Applications: Used in various periodontal procedures to enhance healing and regeneration.

3. Intraoral Cancellous Bone and Marrow

   • Sources: Healing bony wounds, extraction sockets, edentulous ridges, mandibular retromolar areas, and maxillary tuberosity.
   • Applications: Provides a rich source of osteogenic cells and growth factors for bone regeneration.

4. Extraoral Cancellous Bone and Marrow

   • Sources: Obtained from the anterior or posterior iliac crest.
   • Advantages: Generally offers the greatest potential for new bone growth due to the abundance of cancellous bone and marrow.

B. Bone Allografts

Bone allografts are harvested from donors and can be classified into three main types:

1. Undermineralized Freeze-Dried Bone Allograft (FDBA)

   • Introduction: Introduced in 1976 by Mellonig et al.
   • Process: Freeze drying removes approximately 95% of the water from bone, preserving morphology, solubility, and chemical integrity while reducing antigenicity.
   • Efficacy: FDBA combined with autogenous bone is more effective than FDBA alone, particularly in treating furcation involvements.

2. Demineralized (Decalcified) FDBA

   • Mechanism: Demineralization enhances osteogenic potential by exposing bone morphogenetic proteins (BMPs) in the bone matrix.
   • Osteoinduction vs. Osteoconduction: Demineralized grafts induce new bone formation (osteoinduction), while undermineralized allografts facilitate bone growth by providing a scaffold (osteoconduction).

3. Frozen Iliac Cancellous Bone and Marrow

   • Usage: Used sparingly due to variability in outcomes and potential complications.

Comparison of Allografts and Alloplasts

• Clinical Outcomes: Both FDBA and DFDBA have been compared to porous particulate hydroxyapatite, showing little difference in post-treatment clinical parameters.
• Histological Healing: Grafts of DFDBA typically heal with regeneration of the periodontium, while synthetic bone grafts (alloplasts) heal by repair, which may not restore the original periodontal architecture.

Periodontal Medications and Their Uses

Periodontal medications play a crucial role in the management of periodontal diseases, aiding in the treatment of infections, inflammation, and tissue regeneration. Understanding the various types of medications and their specific uses is essential for effective periodontal therapy.

Types of Periodontal Medications

1. Antibiotics:

   • Uses:
     • Used to treat bacterial infections associated with periodontal disease.
     • Commonly prescribed antibiotics include amoxicillin, metronidazole, and doxycycline.
   • Mechanism:
     • They help reduce the bacterial load in periodontal pockets, promoting healing and reducing inflammation.

2. Antimicrobial Agents:

   • Chlorhexidine:
     • Uses: A topical antiseptic used as a mouth rinse to reduce plaque and gingivitis.
     • Mechanism: It disrupts bacterial cell membranes and inhibits bacterial growth.
   • Tetracycline:
     • Uses: Can be used topically in periodontal pockets to reduce bacteria.
     • Mechanism: Inhibits protein synthesis in bacteria, reducing their ability to cause infection.

3. Anti-Inflammatory Medications:

   • Non-Steroidal Anti-Inflammatory Drugs (NSAIDs):
     • Uses: Used to manage pain and inflammation associated with periodontal disease.
     • Examples: Ibuprofen and naproxen.
   • Corticosteroids:
     • Uses: May be used in severe cases to reduce inflammation.
     • Mechanism: Suppress the immune response and reduce inflammation.

4. Local Delivery Systems:

   • Doxycycline Gel (Atridox):
     • Uses: A biodegradable gel that releases doxycycline directly into periodontal pockets.
     • Mechanism: Provides localized antibiotic therapy to reduce bacteria and inflammation.
   • Minocycline Microspheres (Arestin):
     • Uses: A localized antibiotic treatment that is placed directly into periodontal pockets.
     • Mechanism: Releases minocycline over time to combat infection.

5. Regenerative Agents:

   • Bone Grafts and Guided Tissue Regeneration (GTR) Materials:
     • Uses: Used in surgical procedures to promote the regeneration of lost periodontal tissues.
     • Mechanism: Provide a scaffold for new tissue growth and prevent the ingrowth of epithelium into the defect.

6. Desensitizing Agents:

   • Fluoride Varnishes:
     • Uses: Applied to sensitive areas to reduce sensitivity and promote remineralization.
     • Mechanism: Strengthens enamel and reduces sensitivity by occluding dentinal tubules.

Clinical Significance of Periodontal Medications

1. Management of Periodontal Disease:

   • Medications are essential in controlling infections and inflammation, which are critical for the successful treatment of periodontal diseases.

2. Adjunct to Non-Surgical Therapy:

   • Periodontal medications can enhance the effectiveness of non-surgical treatments, such as scaling and root planing, by reducing bacterial load and inflammation.

3. Surgical Interventions:

   • In surgical procedures, medications can aid in healing and regeneration, improving outcomes for patients undergoing periodontal surgery.

4. Patient Compliance:

   • Educating patients about the importance of medications in their treatment plan can improve compliance and overall treatment success.

Bone grafting is a critical procedure in periodontal and dental surgery, aimed at restoring lost bone and supporting the regeneration of periodontal tissues. Various materials can be used for bone grafting, each with unique properties and applications.

A. Osseous Coagulum

• Composition: Osseous coagulum is a mixture of bone dust and blood. It is created using small particles ground from cortical bone.
• Sources: Bone dust can be obtained from various anatomical sites, including:
  • Lingual ridge of the mandible
  • Exostoses
  • Edentulous ridges
  • Bone distal to terminal teeth
• Application: This material is used in periodontal surgery to promote healing and regeneration of bone in areas affected by periodontal disease.

B. Bioactive Glass

• Composition: Bioactive glass consists of sodium and calcium salts, phosphates, and silicon dioxide.
• Function: It promotes bone regeneration by forming a bond with surrounding bone and stimulating cellular activity.

C. HTR Polymer

• Composition: HTR Polymer is a non-resorbable, microporous, biocompatible composite made from polymethyl methacrylate (PMMA) and polyhydroxymethacrylate.
• Application: This material is used in various dental and periodontal applications due to its biocompatibility and structural properties.

D. Other Bone Graft Materials

• Sclera: Used as a graft material due to its collagen content and biocompatibility.
• Cartilage: Can be used in certain grafting procedures, particularly in reconstructive surgery.
• Plaster of Paris: Occasionally used in bone grafting, though less common due to its non-biological nature.
• Calcium Phosphate Biomaterials: These materials are osteoconductive and promote bone healing.
• Coral-Derived Materials: Natural coral can be processed to create a scaffold for bone regeneration.